Johnson Controls Q2: Strong Orders, Record Backlog, but Conversion and Valuation Remain Key Risks

What happened

Johnson Controls reported strong Q2 FY2026 results, with orders up 30% YoY and a record backlog of $20.0B, driven by sustained demand from large-scale data center projects. Management raised FY26 guidance to ~6% organic sales growth and ~$4.85 adjusted EPS with ~100% free cash flow conversion, but cautioned that backlog timing involves numerous uncertainties. Despite the apparent momentum, the stock trades at a premium valuation of 24.7x P/E and 30.6x EV/EBITDA, leaving no margin of safety if conversion lags. The security divestiture catalyst remains weak, as a component of EMEA Security was held for sale with a $50M impairment and closed with no expected gain/loss, undercutting the sum-of-the-parts narrative. Investors should focus on the gap between orders and revenue conversion, as persistent sales growth near 6% versus 30% order growth would confirm timing friction and warrant a cautious stance.

Implication

The Q2 results confirm that data center cooling demand is real and driving orders, but the key issue is whether backlog will convert into revenue and cash at the guided rate. Valuation at 24.7x P/E offers little downside protection if the conversion narrative disappoints, especially since net debt/EBITDA is 3.4x and the company is aggressively buying back shares at elevated prices. The security divestiture process has so far been value-dilutive, with a $50M impairment on a small component, and the larger $4-5B divestiture rumor remains unconfirmed and unlikely to be a near-term catalyst. Over the next 6-9 months, the stock's performance depends on organic sales inflecting above ~6% and FCF conversion staying near 100%, which would justify the premium multiple. Until such evidence emerges, the risk/reward is unfavorable: the base case value of $150 implies only ~4% upside from $143.80, while the bear case of $110 implies 23% downside, suggesting a wait-and-see approach.

Thesis delta

The Q2 transcript reinforces the existing narrative of strong demand but does not resolve the conversion uncertainty; the order-to-sales gap remains wide. As a result, the thesis shifts from 'hope for acceleration' to 'require proof of conversion' within the next two quarters. This maintains the WAIT rating but lowers the conviction that backlog will mechanically translate into EPS growth.